{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:01:49Z","timestamp":1793642509857,"version":"4.5.1"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_raon-2019-0048_s_005_w2aab3b8b9b1b7b1aab1c16b1Aa\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is one of the most frequent malignancies among females worldwide. Increasing evidence have indicated the participation of long noncoding RNAs (lncRNAs) in the progression and metastasis of cervical cancer. Our present study was conducted to explore the effects of lncRNA plasmacytoma variant translocation 1 (PVT1) on the progression of cervical cancer and the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0048_s_006_w2aab3b8b9b1b7b1aab1c16b2Aa\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Expressions of PVT1, miR-140-5p and Smad3 in cervical cancer cell lines were detected by qRT-PCR and western blotting. Bioinformatics analysis and luciferase assays were used to elucidate the potential correlations between PVT1, miR-140-5p and Smad3. The roles of PVT1 on the progression of cervical cancer cells were determined by transfecting sh-RNA through series function assays such as colony formation assay, wound healing assay, transwell assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0048_s_007_w2aab3b8b9b1b7b1aab1c16b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PVT1 and Smad3 were upregulated, and miR-140-5p was downregulated in cervical cancer cells. PVT1 could bind directly with miR-140-5p, and Smad3 was a downstream target of miR-140-5p. Inhibition of PVT1 could enhance expression of miR-140-5p, inhibit the expression of Smad3, significantly inhibited the proliferation, migration, invasion in cervical cancer cells. While transfection of miR-140-5p inhibitor could partially reverse the above changes in cervical cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0048_s_008_w2aab3b8b9b1b7b1aab1c16b4Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results revealed that PVT1 could promote the proliferation and metastasis via increasing the Smad3 expression by sponging miR-140-5p, which might be a promising prognostic and therapeutic target for cervical cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/raon-2019-0048","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T05:02:16Z","timestamp":1571374936000},"page":"443-452","source":"Crossref","is-referenced-by-count":92,"title":["LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer"],"prefix":"10.2478","volume":"53","author":[{"given":"Qing-Qing","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hunan Provincial People\u2019s Hospital , Changsha , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hunan Provincial People\u2019s Hospital , Changsha , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hunan Provincial People\u2019s Hospital , Changsha , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chang","sequence":"additional","affiliation":[{"name":"Changsha Medical University , Changsha , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"2026071214204693856_j_raon-2019-0048_ref_001_w2aab3b8b9b1b7b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"key":"2026071214204693856_j_raon-2019-0048_ref_002_w2aab3b8b9b1b7b1ab2b1b2Aa","unstructured":"Pang T, Wang S, Gao M, Kang H, Zhao Y, Yao Y, et al. HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer. Iran J Basic Med Sci 2015; 18: 684-90. PMID: 26351560"},{"key":"2026071214204693856_j_raon-2019-0048_ref_003_w2aab3b8b9b1b7b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-60. doi: 10.1038\/nrc2886","DOI":"10.1038\/nrc2886"},{"key":"2026071214204693856_j_raon-2019-0048_ref_004_w2aab3b8b9b1b7b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Santin A D, Zhan F, Bignotti E, Siegel E R, Cane S, Bellone S, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005; 331: 269-91. doi: 10.1016\/j.virol.2004.09.045","DOI":"10.1016\/j.virol.2004.09.045"},{"key":"2026071214204693856_j_raon-2019-0048_ref_005_w2aab3b8b9b1b7b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget 2014; 5: 10976-96. doi: 10.18632\/ oncotarget.2770","DOI":"10.18632\/oncotarget.2770"},{"key":"2026071214204693856_j_raon-2019-0048_ref_006_w2aab3b8b9b1b7b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Sun L, Luo H, Liao Q, Bu D, Zhao G, Liu C, et al. Systematic study of human long intergenic non-coding RNAs and their impact on cancer. Sci China Life Sci 2013; 56: 324-34. doi: 10.1007\/s11427-013-4460-x","DOI":"10.1007\/s11427-013-4460-x"},{"key":"2026071214204693856_j_raon-2019-0048_ref_007_w2aab3b8b9b1b7b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, et al. Pan-cancer analyses reveal long intergenic non-coding RNAs relevant to tumor diagnosis, subtyping and prognosis. EBioMedicine 2016; 7: 62-72. doi: 10.1016\/j. ebiom.2016.03.023","DOI":"10.1016\/j.ebiom.2016.03.023"},{"key":"2026071214204693856_j_raon-2019-0048_ref_008_w2aab3b8b9b1b7b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Yang M, Zhai X, Xia B, Wang Y, Lou G. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Tumour Biol 2015; 36: 7615-22. doi: 10.1007\/s13277-015-3465-4","DOI":"10.1007\/s13277-015-3465-4"},{"key":"2026071214204693856_j_raon-2019-0048_ref_009_w2aab3b8b9b1b7b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Han D, Wang J, Cheng G. LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p\/CCND1 axis. Oncotarget 2018; 9: 2395-409. doi: 10.18632\/oncotarget.23416","DOI":"10.18632\/oncotarget.23416"},{"key":"2026071214204693856_j_raon-2019-0048_ref_010_w2aab3b8b9b1b7b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Tian Z, Cao S, Li C, Xu M, Wei H, Yang H, et al. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31\/ CDK1. J Cell Physiol 2019; 234: 4799-4811. doi: 10.1002\/jcp.27279","DOI":"10.1002\/jcp.27279"},{"key":"2026071214204693856_j_raon-2019-0048_ref_011_w2aab3b8b9b1b7b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Chen Y, Du H, Bao L, Liu W. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med 2018; 15: 238-250. doi: 10.20892\/j.issn.2095-3941.2017.0174","DOI":"10.20892\/j.issn.2095-3941.2017.0174"},{"key":"2026071214204693856_j_raon-2019-0048_ref_012_w2aab3b8b9b1b7b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Ding Y, Fang Q, Li Y, Wang Y. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140. Mamm Genome 2019. doi: 10.1007\/s00335-019-09808-1","DOI":"10.1007\/s00335-019-09808-1"},{"key":"2026071214204693856_j_raon-2019-0048_ref_013_w2aab3b8b9b1b7b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader J S. The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis. PLoS One 2016; 11: e0156274. doi: 10.1371\/journal. pone.0156274","DOI":"10.1371\/journal.pone.0156274"},{"key":"2026071214204693856_j_raon-2019-0048_ref_014_w2aab3b8b9b1b7b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Dong G, Liang X, Wang D, Gao H, Wang L, Wang L, et al. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation. Med Oncol 2014; 31: 57. doi: 10.1007\/s12032-014-0057-x","DOI":"10.1007\/s12032-014-0057-x"},{"key":"2026071214204693856_j_raon-2019-0048_ref_015_w2aab3b8b9b1b7b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Muhammad S, Tang Q, Wei L, Zhang Q, Wang G, Muhammad B U, et al. miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene. Exp Ther Med 2019; 17: 260-272. doi: 10.3892\/etm.2018.6902","DOI":"10.3892\/etm.2018.6902"},{"key":"2026071214204693856_j_raon-2019-0048_ref_016_w2aab3b8b9b1b7b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Ma H P, Kong W X, Li X Y, Li W, Zhang Y, Wu Y. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K\/AKT pathway by targeting EGFR. Oncol Rep 2019. doi: 10.3892\/or.2019.6983","DOI":"10.3892\/or.2019.6983"},{"key":"2026071214204693856_j_raon-2019-0048_ref_017_w2aab3b8b9b1b7b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-91. doi: 10.1016\/j.cell.2009.02.005","DOI":"10.1016\/j.cell.2009.02.005"},{"key":"2026071214204693856_j_raon-2019-0048_ref_018_w2aab3b8b9b1b7b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y, et al. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer 2017; 16: 139. doi: 10.1186\/s12943-017-0708-6","DOI":"10.1186\/s12943-017-0708-6"},{"key":"2026071214204693856_j_raon-2019-0048_ref_019_w2aab3b8b9b1b7b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Lan H, Chen W, He G, Yang S. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother 2015; 75: 117-22. doi: 10.1016\/j.biopha.2015.07.035","DOI":"10.1016\/j.biopha.2015.07.035"},{"key":"2026071214204693856_j_raon-2019-0048_ref_020_w2aab3b8b9b1b7b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xu J. MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression. Biochem Biophys Res Commun 2016; 473: 342-8. doi: 10.1016\/j.bbrc.2016.03.116","DOI":"10.1016\/j.bbrc.2016.03.116"},{"key":"2026071214204693856_j_raon-2019-0048_ref_021_w2aab3b8b9b1b7b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Li J, Zou K, Yu L, Zhao W, Lu Y, Mao J, et al. MicroRNA-140 inhibits the epithelial-mesenchymal transition and metastasis in colorectal cancer. Mol Ther Nucleic Acids 2018; 10: 426-37. doi: 10.1016\/j.omtn.2017.12.022","DOI":"10.1016\/j.omtn.2017.12.022"},{"key":"2026071214204693856_j_raon-2019-0048_ref_022_w2aab3b8b9b1b7b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Dong P, Xiong Y, Hanley S J B, Yue J, Watari H. Musashi-2, a novel onco-protein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation. J Exp Clin Cancer Res 2017; 36: 150. doi: 10.1186\/s13046-017-0617-y","DOI":"10.1186\/s13046-017-0617-y"},{"key":"2026071214204693856_j_raon-2019-0048_ref_023_w2aab3b8b9b1b7b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Dong J, Su M, Chang W, Zhang K, Wu S, Xu T. Long non-coding RNAs on the stage of cervical cancer. Oncol Rep 2017; 38: 1923-31. doi: 10.3892\/ or.2017.5905","DOI":"10.3892\/or.2017.5905"},{"key":"2026071214204693856_j_raon-2019-0048_ref_024_w2aab3b8b9b1b7b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Zhang Y, Yang G, Luo Y. Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a. Exp Ther Med 2019; 17: 1337-45. doi: 10.3892\/etm.2018.7083","DOI":"10.3892\/etm.2018.7083"},{"key":"2026071214204693856_j_raon-2019-0048_ref_025_w2aab3b8b9b1b7b1ab2b1c25Aa","unstructured":"Zou M F, Ling J, Wu Q Y, Zhang C X. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci 2018; 22: 7183-8. doi: 10.26355\/eurrev_201811_16251"},{"key":"2026071214204693856_j_raon-2019-0048_ref_026_w2aab3b8b9b1b7b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Wan L, Sun M, Liu G J, Wei C C, Zhang EB, Kong R, et al. Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther 2016; 15: 1082-94. doi: 10.1158\/1535-7163.MCT-15-0707","DOI":"10.1158\/1535-7163.MCT-15-0707"},{"key":"2026071214204693856_j_raon-2019-0048_ref_027_w2aab3b8b9b1b7b1ab2b1c27Aa","unstructured":"Ping G, Xiong W, Zhang L, Li Y, Zhang Y, Zhao Y. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res 2018; 10: 138-49. PMID: 29423000"},{"key":"2026071214204693856_j_raon-2019-0048_ref_028_w2aab3b8b9b1b7b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-66. doi: 10.1016\/j. canlet.2013.06.013","DOI":"10.1016\/j.canlet.2013.06.013"},{"key":"2026071214204693856_j_raon-2019-0048_ref_029_w2aab3b8b9b1b7b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Kim J, Piao H L, Kim B J, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 2018; 50: 1705-15. doi: 10.1038\/s41588-018-0252-3","DOI":"10.1038\/s41588-018-0252-3"},{"key":"2026071214204693856_j_raon-2019-0048_ref_030_w2aab3b8b9b1b7b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Zhang R, Li J, Yan X, Jin K, Li W, Liu X, et al. Long noncoding RNA plasmacytoma variant translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26b. Med Sci Monit 2018; 24: 8685-92. doi: 10.12659\/MSM.910955","DOI":"10.12659\/MSM.910955"},{"key":"2026071214204693856_j_raon-2019-0048_ref_031_w2aab3b8b9b1b7b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Huang V. Endogenous miRNAa: miRNA-mediated gene upregulation. Adv Exp Med Biol 2017; 983: 65-79. doi: 10.1007\/978-981-10-4310-9_5","DOI":"10.1007\/978-981-10-4310-9_5"},{"key":"2026071214204693856_j_raon-2019-0048_ref_032_w2aab3b8b9b1b7b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Yamazaki K, Masugi Y, Effendi K, Tsujikawa H, Hiraoka N, Kitago M, et al. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Lab Invest 2014; 94: 683-91. doi: 10.1038\/labinvest.2014.53","DOI":"10.1038\/labinvest.2014.53"},{"key":"2026071214204693856_j_raon-2019-0048_ref_033_w2aab3b8b9b1b7b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Fan Q, Qiu M T, Zhu Z, Zhou J H, Chen L, Zhou Y, et al. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-beta\/Smad3 signaling pathway. Oncol Rep 2015; 34: 1787-94. doi: 10.3892\/or.2015.4143","DOI":"10.3892\/or.2015.4143"},{"key":"2026071214204693856_j_raon-2019-0048_ref_034_w2aab3b8b9b1b7b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Chen X, Xiong D, Ye L, Wang K, Huang L, Mei S, et al. Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell Int 2019; 19: 45. doi: 10.1186\/s12935-019-0744-y","DOI":"10.1186\/s12935-019-0744-y"},{"key":"2026071214204693856_j_raon-2019-0048_ref_035_w2aab3b8b9b1b7b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Su Y, Xiong J, Hu J, Wei X, Zhang X, Rao L. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Oncotarget 2016; 7: 68397-411. doi: 10.18632\/oncotarget.11722","DOI":"10.18632\/oncotarget.11722"},{"key":"2026071214204693856_j_raon-2019-0048_ref_036_w2aab3b8b9b1b7b1ab2b1c36Aa","unstructured":"Yang J P, Yang X J, Xiao L, Wang Y. Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer. Eur Rev Med Pharmacol Sci 2016; 20: 3980-6."}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/raon\/53\/4\/article-p443.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2019-0048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:56:45Z","timestamp":1783900605000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2019-0048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,10,18]]},"published-print":{"date-parts":[[2019,10,18]]}},"alternative-id":["10.2478\/raon-2019-0048"],"URL":"https:\/\/doi.org\/10.2478\/raon-2019-0048","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]}}}